In summary, although in acute inflammatory states (for example, during IFNα-based immunotherapy) IDO activation is strongly related to the onset of depressive-like behaviors, this appears not to be the case in clinical depression since only some of those individuals, that is, those with physio-somatic symptoms or suicidal behavior, show relative increases in TRYCAT levels. The gene discussed is IDO1; the disease is major depressive disorder.